FT. LAUDERDALE, Fla., Oct. 29, 2008 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its Tactile Guidance System(tm) (TGS(tm)), an advanced robotic-arm solution, and its implants for minimally invasive orthopedic knee procedures, known as MAKOplasty(r), today announced that it has entered into a definitive agreement for an equity financing of up to $60 million, with initial gross proceeds of $40 million and conditional access to an additional $20 million. The $40 million tranche is scheduled to close on Friday, October 31, 2008, subject to the satisfaction of certain customary closing conditions.
